Gian Mario Tiboni
Sezione di Scienze della Riproduzione
Dipartimento di Medicina e Scienze dell'Invecchiamento
Facolta di Medicina e Chirurgia
Universita "G. d'Annunzio"
Italy
Name/email consistency: high
- Extrapituitary Actions of GnRH Antagonists: Prospects for in vitro Fertilization Programs. Impicciatore, G.G., Mario Tiboni, G. Curr. Pharm. Des. (2012)
- Ovulation inducing agents and cancer risk: review of literature. Impicciatore, G.G., Tiboni, G.M. Curr. Drug. Saf (2011)
- Fluconazole alters CYP26 gene expression in mouse embryos. Tiboni, G.M., Marotta, F., Carletti, E. Reprod. Toxicol. (2009)
- Impact of estrogen replacement on letrozole-induced embryopathic effects. Tiboni, G.M., Marotta, F., Castigliego, A.P., Rossi, C. Hum. Reprod. (2009)
- Teratogenic effects in mouse fetuses subjected to the concurrent in utero exposure to miconazole and metronidazole. Tiboni, G.M., Marotta, F., Castigliego, A.P. Reprod. Toxicol. (2008)
- Effects of the aromatase inhibitor letrozole on in utero development in rats. Tiboni, G.M., Marotta, F., Rossi, C., Giampietro, F. Hum. Reprod. (2008)
- Progestational agents prevent preterm birth induced by a nitric oxide synthesis inhibitor in the mouse. Tiboni, G.M., Del Corso, A., Marotta, F. In. Vivo (2008)
- Production of axial skeletal malformations with the nitric oxide synthesis inhibitor NG-nitro-L-arginine methyl ester (L-NAME) in the mouse. Tiboni, G.M., Marotta, F., Barbacane, L. Birth Defects Res. B Dev. Reprod. Toxicol. (2007)
- Defining critical periods for itraconazole-induced cleft palate, limb defects and axial skeletal malformations in the mouse. Tiboni, G.M., Marotta, F., Del Corso, A., Giampietro, F. Toxicol. Lett. (2006)
- Serological testing for celiac disease in women undergoing assisted reproduction techniques. Tiboni, G.M., de Vita, M.G., Faricelli, R., Giampietro, F., Liberati, M. Hum. Reprod. (2006)
- Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence. Tiboni, G.M., Giampietro, F. Pediatr. Res. (2005)
- Teratological consequences of nitric oxide synthesis inhibition. Tiboni, G.M., Clementini, E. Curr. Pharm. Des. (2004)
- Influence of cigarette smoking on vitamin E, vitamin A, beta-carotene and lycopene concentrations in human pre-ovulatory follicular fluid. Tiboni, G.M., Bucciarelli, T., Giampietro, F., Sulpizio, M., Di Ilio, C. Int. J. Immunopathol. Pharmacol (2004)
- The nitric oxide synthesis inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME) causes limb defects in mouse fetuses: protective effect of acute hyperoxia. Tiboni, G.M., Giampietro, F., Di Giulio, C. Pediatr. Res. (2003)
- Additional investigation on the potentiation of phenytoin teratogenicity by fluconazole. Tiboni, G.M., Giampietro, F., Angelucci, S., Moio, P., Bellati, U., Di Ilio, C. Toxicol. Lett. (2003)
- Transplacental exposure to methylene blue initiates teratogenesis in the mouse: preliminary evidence for a mechanistic implication of cyclic GMP pathway disruption. Tiboni, G.M., Lamonaca, D. Teratology (2001)
- The soluble guanylate cyclase inhibitor methylene blue evokes preterm delivery and fetal growth restriction in a mouse model. Tiboni, G.M., Giampietro, F., Lamonaca, D. In. Vivo (2001)
- Inhibition of nitric oxide synthesis causes preterm delivery in the mouse. Tiboni, G.M., Giampietro, F. Hum. Reprod. (2000)
- Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin. Tiboni, G.M., Iammarrone, E., Giampietro, F., Lamonaca, D., Bellati, U., Di Ilio, C. Teratology (1999)
